Lisinopril And Hydrochlorothiazide Tablet
Product Images NDC 50090-6204

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lisinopril And Hydrochlorothiazide (NDC 50090-6204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lisinopril)

Chemical structure of Lisinopril, an active ingredient in Lisinopril and Hydrochlorothiazide Tablets, depicted as a molecular diagram showing bonds and atoms.*

FDA Label Image

Chemical Structure (HCTZ)

Chemical structure diagram of Lisinopril and Hydrochlorothiazide, showing the molecular arrangement with labeled atoms and bonds characteristic of the combination active ingredients in these tablets.*

FDA Label Image

Label Image (Lbl500906204)

The packaging label for Lisinopril and Hydrochlorothiazide Tablets 20 mg/12.5 mg from A-S Medication Solutions. The label includes lot and expiration details, dosage instructions, a quantity of 30 tablets, and a note to protect from excessive light and humidity. It also features the product NDC 50090-6204.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.